Capricor Therapeutics

FDA
Favicon Fierce Biotech

FDA plans real-time release of drug rejection letters

Alongside the new policy, the FDA released 89 new complete response letters, adding to the more than 200 that were previously made public in July.
Darren Incorvaia Sep 4, 2025 1:45pm
Getty ImagesNaeblys

Capricor touts exosomes as better mRNA delivery vehicle

Mar 16, 2021 9:45am